319 related articles for article (PubMed ID: 11972582)
21. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study.
Nelles G; Delbrück A; Schulze L; Kademann B; Bornhoevd K; Schäfer S; Schäuble B;
Headache; 2009; 49(10):1454-65. PubMed ID: 19804392
[TBL] [Abstract][Full Text] [Related]
22. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
24. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
25. A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease.
Huntington Study Group
Neurology; 2001 Aug; 57(3):397-404. PubMed ID: 11502903
[TBL] [Abstract][Full Text] [Related]
26. Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I.
Carotenuto M; Esposito M
Neurol Sci; 2013 Nov; 34(11):1905-9. PubMed ID: 23532548
[TBL] [Abstract][Full Text] [Related]
27. [Coenzyme Q10: contractile dysfunction of the myocardial cell and metabolic therapy].
Davini A; Cellerini F; Topi PL
Minerva Cardioangiol; 1992 Nov; 40(11):449-53. PubMed ID: 1291925
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
29. Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans.
Colquhoun DM; Jackson R; Walters M; Hicks BJ; Goldsmith J; Young P; Strakosch C; Kostner KM
Eur J Clin Invest; 2005 Apr; 35(4):251-8. PubMed ID: 15816994
[TBL] [Abstract][Full Text] [Related]
30. Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis.
Vikelis M; Dermitzakis EV; Vlachos GS; Soldatos P; Spingos KC; Litsardopoulos P; Kararizou E; Argyriou AA
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375459
[TBL] [Abstract][Full Text] [Related]
31. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
[TBL] [Abstract][Full Text] [Related]
32. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
33. Italian multicenter study on the efficacy and safety of coenzyme Q10 as adjuvant therapy in heart failure.
Lampertico M; Comis S
Clin Investig; 1993; 71(8 Suppl):S129-33. PubMed ID: 8241696
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of CoQ10 as supplementation for migraine: A meta-analysis.
Zeng Z; Li Y; Lu S; Huang W; Di W
Acta Neurol Scand; 2019 Mar; 139(3):284-293. PubMed ID: 30428123
[TBL] [Abstract][Full Text] [Related]
35. Topiramate in migraine prevention: results of a large controlled trial.
Silberstein SD; Neto W; Schmitt J; Jacobs D;
Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
[TBL] [Abstract][Full Text] [Related]
36. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
Young W; Shaw J; Bloom M; Gebeline-Myers C
Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
[TBL] [Abstract][Full Text] [Related]
37. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
[TBL] [Abstract][Full Text] [Related]
39. [Coenzyme q10 in childhood: detection methods, reference values and disease-related changes in the coenzyme q10 status].
Menke T
Georgian Med News; 2008 Mar; (156):24-32. PubMed ID: 18403806
[TBL] [Abstract][Full Text] [Related]
40. Topiramate for migraine prevention: a randomized controlled trial.
Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
